TBPH
Theravance Biopharma, Inc. · Healthcare · Market cap $884.2M(Price slightly stale)
Insiders sold $6.1M net in the last 90 days ·2 sellers, 0 buyers· latest Form 4 filed Sep 17, 2026
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$9.3M
reported sales (SEC code S)
Unique Insiders
3
in the rolling window
Latest filing
Sep 28, 2026
Farnum Rhonda
Theravance Biopharma, Inc. (TBPH) has 50 SEC Form 4 filings (83 transaction rows) in the rolling window, disclosed by 3 distinct insiders. Most recent filing: Sep 28, 2026.
Inside the rolling window, 3 insiders at Theravance Biopharma, Inc. reported no open-market purchases and 11 open-market sales totaling $9.3M. The most active filer is 10% Owner Samaha Eli with 5 filings. Insiders have net sold $6.4M over the trailing 6 months. The most recent open-market filing is a sale of 13,314 shares by SVP, COMM & MEDICAL AFFAIRS Farnum Rhonda, dated Sep 15, 2026, worth $227K.
- Industry:Biotechnology
- CEO:Rick E. Winningham
- Employees:90
- HQ:South San Francisco, CA, US
- IPO:2014-05-16
| Source | |||||||
|---|---|---|---|---|---|---|---|
Farnum RhondaFirst in 3 months | SVP, COMM & MEDICAL AFFAIRS | Sale | 13,314 | $227K | Sep 17 | -0.1% | SEC ↗ |
| 10% Owner | Sale | 1,400 | $24K | Jul 8 | +0.2% | SEC ↗ | |
| 10% Owner | Sale | 5,564 | $96K | Jul 8 | +0.2% | SEC ↗ | |
Samaha EliFirst filing | 10% Owner | Sale | 273,871 | $4.7M | Jul 1 | +0.3% | SEC ↗ |
Samaha EliFirst filing | 10% Owner | Sale | 25,027 | $429K | Jul 1 | +0.3% | SEC ↗ |
Samaha EliFirst filing | 10% Owner | Sale | 37,799 | $643K | Jul 1 | +0.3% | SEC ↗ |
Farnum RhondaFirst in 3 months | SVP, COMM & MEDICAL AFFAIRS | Sale | 13,314 | $218K | Jun 17 | +1.9% | SEC ↗ |
Farnum RhondaFirst in 3 months | SVP, COMM & MEDICAL AFFAIRS | Sale | 31,067 | $434K | Mar 18 | — | SEC ↗ |
Farnum RhondaFirst filing | SVP, COMM & MEDICAL AFFAIRS | Sale | 31,067 | $583K | Dec 5 | — | SEC ↗ |
| Director | Sale | 29,501 | $590K | Dec 1 | — | SEC ↗ | |
| Director | Sale | 74,500 | $1.4M | Nov 14 | — | SEC ↗ |
Earnings: last 7 quarters
Congress trading TBPH 1 all-time
- DRep. George WhitesidesOther$15,001 - $50,0002025-03-24
STOCK Act disclosures are filed up to 45 days after the trade. Amount is a disclosed range, not an exact figure.
Frequently asked questions
How many SEC Form 4 insider filings does TBPH have?
Theravance Biopharma, Inc. (TBPH) has 50 SEC Form 4 filings (83 transaction rows) in the rolling 365-day window, disclosed by 3 distinct insiders. Most recent filing: Sep 28, 2026.
When was the most recent SEC Form 4 filing for TBPH?
The most recent Form 4 filing for TBPH on Tracefour is dated Sep 28, 2026.
Who is the most active insider at TBPH?
The most active SEC Form 4 filer at TBPH in the rolling window is 10% Owner Samaha Eli, with 5 filings.
What is the net insider flow at TBPH over the last 6 months?
Over the trailing 180 days, insiders at TBPH have net sold $6.4M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at TBPH in the current window?
Inside the rolling window, insiders at TBPH bought $0 and sold $9.3M based on SEC Form 4 filings.
Can I get alerts for TBPH insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Theravance Biopharma, Inc. (TBPH). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Theravance Biopharma, Inc. is in the Healthcare sector.